« Previous
Next »
Taiwanese Journal of Obstetrics and Gynecology
Volume 46, Issue 2
, Pages 146-151
, June 2007
Comparison of Immunohistochemical and Fluorescence In Situ Hybridization Assessment for HER-2/neu Status in Taiwanese Breast Cancer Patients
References
- Use of chemo-therapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 . N Engl J Med . 2001;344:783–792
- . HER-2/neu overexpression in Chinese breast cancers: correlation with other prognostic factors . J Formos Med Assoc . 1995;94:660–665
-
HER-2/neu testing in breast cancer
.
Am J Clin Pathol
. 2003;120(Suppl):S53–S71
- . Comparison of immunohistochemical and fluorescence in situ hybridization assessment of HER-2 status in routine practice . Am J Clin Pathol . 2005;123:766–770
- Comparative methodological analysis of erbB-2/HER-2 gene dosage, chromosomal copy number and protein overexpression in breast carcinoma tissues for diagnostic use . Histopathology . 2000;37:411–419
- . Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: apparent immunohisto-chemical false-positives do not get the message . J Clin Oncol . 2001;19:2714–2721
- . HER-2/neu testing in breast carcinoma: a combined immunohistochemical and fluorescence in situ hybridization approach . Mod Pathol . 2000;13:866–873
- . Expression of HER-2/NEU oncoprotein in familial and non-familial breast cancer . Kaohsiung J Med Sci . 2001;17:64–76
- The clinical significance between activation of nuclear factor kappa B transcription factor and overexpression of HER-2/neu oncoprotein in Taiwanese patients with breast cancer . Clin Chim Acta . 2003;334:137–144
- . p53 and c-erbB-2 but not bcl-2 are predictive of metastasis-free survival in breast cancer patients receiving post-mastectomy adjuvant radiotherapy in Taiwan . Jpn J Clin Oncol . 2002;32:332–339
- . erb-b2 amplification by fluorescence in situ hybridization in breast cancer specimens read as 2+ in immunohistochemical analysis . Am J Clin Pathol . 2005;124:97–102
- . Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: A direct comparison of fluorescence in situ hybridization and immunohistochemistry . J Clin Oncol . 2000;18:3651–3664
- HER-2/neu analysis in archival tissue samples of human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization . J Clin Oncol . 2001;19:354–363
- . HER2 testing . CAP Today . 2001;15:8–9
- HER2 analysis in breast cancer: reduced immunoreactivity in FISH non-informative cancer biopsies . Int J Oncol . 2004;25:1551–1557
- Calibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French multicentre GEFPICS study . Histopathology . 2003;42:337–347
- The incidence of topoisomerase II-alpha genomic alterations in adenocarcinoma of the breast and their relationship to human epidermal growth factor receptor-2 gene amplification: a fluorescence in situ hybridization study . Hum Pathol . 2005;36:348–356
PII: S1028-4559(07)60008-4
doi: 10.1016/S1028-4559(07)60008-4
© 2007 Taiwan Association of Obstetric & Gynecology. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Taiwanese Journal of Obstetrics and Gynecology
Volume 46, Issue 2
, Pages 146-151
, June 2007
